1 Recently, we provided evidence for cyclic adenosine 5'-diphosphate-ribose, cADP-ribose, as a second messenger in Jurkat T-lymphocytes upon stimulation of the T-cell receptor/CD3-complex . cADP-ribose mobilizes Ca 2+ from an intracellular Ca 2+ store which is sensitive to caeine and gated by the ryanodine receptor/Ca 2+ release channel. In the present study we investigated the ability of the trypanocidal drug, suramin, to activate the ryanodine receptor of Tcells. Since suramin cannot permeate the plasma membrane, it was necessary to microinject the drug into Fura-2 loaded T-lymphocytes. 2 In a dose dependent manner suramin increased the intracellular Ca 2+ concentration. The doseresponse curve is very steep and calculates for an EC 50 of 7.6+2.9 mM suramin in the injection pipette.
Introduction
The cytosolic Ca 2+ concentration is essentially linked with the immunoreactivity of T-lymphocytes (Guse, 1998) . Activation of the T cell receptor/CD3-complex results in elevated cytosolic Ca 2+ concentrations. In this process participation of the InsP 3 -dependent Ca 2+ pool has been described extensively (Jayaraman et al., 1995;  for review see Crabtree & Clipstone, 1994) . Recently, we have demonstrated that activation of the T-cell receptor/CD3-complex is accompanied by a sustained generation of the novel second messenger, cyclic adenosine 5'-diphosphate ribose, cADP-ribose, which is observed in parallel to sustained Ca 2+ signalling . The molecular target for the cADP-ribose induced Ca 2+ signals was identi®ed as the ryanodine receptor (RyR).
The RyR like the InsP 3 -receptor, is a member of the family of intracellular Ca 2+ release channels. The RyR plays an essential role in the excitation-contraction coupling of the skeletal and cardiac muscle (Marks, 1997) . The ion channel consists of a tetramer of four identical *560 kDa subunits. The physiological regulation of the skeletal (type 1) and cardiac (type 2) isoform of the RyR involves gating by the plasma membrane dihydropyridine receptor via an electromechanical coupling or a Ca 2+ in¯ux, respectively (Clapham, 1995) . Both isoforms of the RyR seem to be restricted to excitable cells; however, a third isoform (type 3) was cloned and termed the brain isoform (Hakamata et al., 1992; Nakashima et al., 1997) . Although the RyR type 3 is abundant in some brain areas it is also found in non-excitable cells like spleen and testis (Giannini et al., 1995) . Due to the low expression level of type 3 RyR little is known about the physiological and pharmacological regulation of this RyR isoform. Most of the information of the type 3 ion channel is derived from the primary sequence. The distribution of the putative transmembrane domains of the RyR type 1 and 2 are also found in the RyR type 3. A nucleotide binding site and three potential calmodulin binding sites are predicted (Leeb & Brenig, 1998) .
In Jurkat T-lymphocytes a RyR was identi®ed by Western blot and [
3 H]-ryanodine binding assays. RT ± PCR with speci®c primers for a COOH-terminal fragment indicated that the RyR in Jurkat T-lymphocytes is the type 3 RyR, while RyR's type 1 and type 2 were absent . This ®nding is corroborated by the sensitivity of T-lymphocytes for cADP-ribose. The RyR's type 1 and type 2 have been found to be insensitive toward exposure to cADP-ribose (Fruen et al., 1994) . The sole presence of the type 3 RyR makes the Jurkat Tlymphocyte a prototypical model system to investigate the physiological and pharmacological regulation of this novel RyR isoform.
The trypanocidal drug, suramin, serves as a potent agonist on the RyR isoform type 1 and type 2 (Hohenegger et al., 1996) . The negatively charged naphthylsulfonyl residues turned out to be essential for the agonistic eects observed for suramin. Otherwise than postulated, the interaction of suramin does not take place via an ATP binding site of the ryanodine receptor (Emmick et al., 1994; Hohenegger et al., 1996) . Calmodulin, a negatively charged Ca 2+ binding protein is a dualistic regulator of the RyR (Meissner, 1994) . Very recently, we could show that suramin competes with calmodulin for the binding to type 1 RyR (Klinger et al., 1999) . The fact that the type 3 RyR conserved three predictive calmodulin binding sites led us to the question whether this isoform of the ryanodine receptor is sensitive toward suramin or not.
In the present study we have loaded Jurkat T-lymphocytes with Fura 2 and measured the¯uorescence changes due to the addition of suramin. We circumvented the impermeability of the plasma membrane for suramin by usage of the microinjection technique. Upon suramin injection the intracellular Ca 2+ concentration ([Ca 2+ ] i ) of T-cells was elevated in a dose-dependent manner. This Ca 2+ transients were unequivocally mediated via a ryanodine sensitive Ca 2+ pool.
Methods
Materials 8-methoxy cyclic adenosine 5'-diphosphate ribose, (8-OCH 3 -cADP-ribose), was synthesized brie¯y as follows: 8-bromo-AMP was treated with sodium methoxide to convert it into 8-methoxy AMP which was puri®ed by ion-exchange chromatography and subsequently coupled to nicotinamide adenine mononucleotide using dicyclohexyl carbodiimide by a method analogous to that previously reported (Ashamu et al., 1997) . The resulting 8-methoxy NAD was cyclized to 8-methoxy cADP-ribose using Aplysia ADP-ribosyl cyclase and was puri®ed by ion-exchange chromatography and thoroughly characterized by HPLC, NMR and mass spectroscopy. Cyclic ADP-ribose was synthesized from NAD + by cyclization with the Aplysia ADP-ribosyl cyclase and puri®ed by ion-exchange chromatography on Q-sepharose. Both compounds were used as their triethylammonium salts.
D-myo-inositol 1,4,6-trisphosphorothioate (Ins(1,4,6)PS 3 ) was synthesized in an analogous fashion to D-Ins(1,4,6)P 3 (Mills & Potter, 1996) except that the intermediate triphosphite was sulphoxidized as described for the racemic material (Mills et al., 1995) . After puri®cation by ion-exchange chromatography and quanti®cation by total phosphate assay the material was used as its triethylammonium salts.
Digital Ca
2+¯u orescence measurements and analysis of data Cultured Jurkat T-lymphocytes were loaded with Fura2-AM and immobilized to thin glass coverslips (0.2 mm) for microinjection as previously described (Guse et al., 1993; . The cells were kept in a buer containing (mM) NaCl 140, KCl 5, MgS0 4 1, CaCl 2 1, HEPES 20, NaH 2 P0 4 1, glucose 5.5, pH 7.4. The¯uorescence of a single T-lymphocyte was analysed with a digital ratiometric imaging station (PhotoMed GmbH/Photon Technology, Wedel, Germany) using an inverted Axiovert 100¯uorescence microscope (Zeiss, Oberkochen, Germany). The excitation was carried out at 340 nm and 380 nm and the corresponding emission light of 510 nm detected with an CCD camera at a resolution of 5256487 pixel (type C2400-77, Hamamatsu, Garching, Germany) and a data sampling rate of 1 ratio/5 s. Regions of interest covering the investigated injected cell were analysed o line for the 340/380 ratio using the ImageMaster software (PhotoMed GmbH/ Photon Technology, Wedel, Germany). The numerical median ratios and the corresponding free Ca 2+ concentrations were calculated using external calibration.
Microinjection
Microinjection was carried out with an Eppendorf system (transjector type 5246, micromanipulator type 5171; Eppendorf-Netheler-Hinz, Hamburg, Germany) using Femtotips II as pipettes. The compounds were diluted in the intracellular buer (containing (mM): HEPES 20, KCl 110, MgCl 2 2, KH 2 P0 4 5, NaCl 10, pH 7.2) prior to injection to give the concentrations given in the ®gures and ®gure legends. The pipette was positioned on top of the cell and then microinjection was initiated by the semiautomatic injection mode of the system. The parameters of the instrumental settings were identical to that described in Guse et al. (1997) . Under such conditions the injected volume was 1 ± 1.5% of the total cell volume as calibrated by microinjection with thē uorescent dye, Fura 2-free acid.
Miscellaneous procedures
Jurkat T-lymphocytes were cultured in RPMI 1640 medium supplemented with new-born bovine calf serum (10% v v
71
), HEPES (25 mM, pH 7.4) penicillin (100 units ml 71 ), and streptomycin (50 mg ml 71 ). The data were subjected to non-linear, least-squares curve ®tting using the appropriate equations (rectangular hyperbola, Hill equation and monophasic exponential decay), and parameter estimates were derived.
Results
Application of the trypanocidal drug suramin via the microinjection procedure resulted in a tremendous increase in the intracellular Ca 2+ concentration ([Ca 2+ ] i ) in Fura-2 loaded Jurkat T lymphocytes ( Figure 1A ). The suramin induced increase in [Ca 2+ ] i was dose-dependent ( Figure 1B) . Taking the peak-amplitudes of the [Ca 2+ ] i a curve was ®tted according to the Hill equation and calculated for an EC 50 of 7.6+2.9 mM suramin. This concentration equals that of suramin in the microinjection pipette. Using Fura-2 free acid microinjection under identical conditions and subsequent determination of the dye concentration in the injected cell spectro¯uorimetrically, we obtained the dilution factor of a compound using this technique (Guse et al., 1997) . The ®nal concentration of suramin in the Jurkat T-lymphocyte has to be assumed to be 1 ± 1.5% of that present in the microinjection pipette.
The dose-response relationship for suramin is very steep and calculates for a Hill coecient of about four. This ®nding is well in agreement with the previous observation that suramin stimulates open probability of the puri®ed RyR type 1 in single channel recordings with high cooperativity and an EC 50 of about 200 mM (Hohenegger et al., 1996) .
The elevated [Ca 2+ ] i levels were sustained for at least 10 min ( Figure 1A) . We have therefore determined the t 600 value, the time point 10 min after the suramin induced [Ca 2+ ] i peak concentration ( Figure 1C Figure 1C) .
In order to exclude the possibility that the suramin induced increment in [Ca 2+ ] i was triggered by targets of the plasma membrane we applied 1 mM suramin to the extracellular bath solution. No alterations in basal [Ca 2+ ] i were detectable during an observation period of more than 5 min (data not shown). This allows for the assumption that suramin exerted the Ca 2+ mobilizing activity via an intracellular target.
The primary candidate for suramin binding is the RyR present in Jurkat T-lymphocytes . The intracellular co-application of a fully stimulating suramin concentration (10 mM) with the RyR speci®c inhibitor ruthenium red (2 mM) completely abolished the elevation in [Ca 2+ ] i (data not shown). Even during observation times of more than 20 min no eect on [Ca 2+ ] i was observed under these conditions. In one out of ®ve cells co-injected with suramin and ruthenium red we detected spontaneous [Ca 2+ ] i oscillations starting 7 min after the injection time point. Spontaneous [Ca 2+ ] i oscillations occasionally occur also in the absence of any manipulation in approximately 10% of the investigated cells.
The sustained [Ca 2+ ] i levels in response to suramin microinjection might be related to the second intracellular Ca 2+ release channel, the InsP 3 -receptor (Sugiyama et al., 1994) . To prove participation of the InsP 3 -receptor in Jurkat T-lymphocytes, we used the competitive inhibitor, Ins(1,4,6)PS 3 which we have previously described (Guse et al., 1997) . At 80 mM Ins(1,4,6)PS 3 , a concentration which completely suppressed the IP 3 -mediated activation of the InsP 3 -receptor (for overview see Table 1 ), the suramin-induced Ca 2+ transients were shortened ( Figure 2A ). The t 600 values were signi®cantly reduced from 0.53+0.19 mM to 0.26+0.11 mM [Ca 2+ ] i (P50.005), in the absence and presence of the InsP 3 -receptor antagonist, respectively ( Figure 2B ). However, the peak Ca 2+ concentrations were not altered by co-injection of Ins(1,4,6)PS 3 ( Figure 2B ).
In permeabilized T-lymphocytes the presence of ruthenium red only suppressed the cADP-ribose induced [Ca 2+ ] i elevation but not that induced by InsP 3 (summarized in Table 1 ; Guse et al., 1995) . Both compounds, suramin and cADP-ribose, may therefore release Ca 2+ from the same ryanodine-sensitive Ca 2+ -pool. Analogous to the antagonist of the endogenous activator of Ca 2+ mobilization, InsP 3 , we used a direct antagonist of cADP-ribose, 8-OCH 3 -cADP-ribose to possibly identify participation of cADP-ribose in the suramin-induced Ca 2+ -transient ( Figure 3 and Table 1 ). cADP-ribose is a novel second messenger leading to activation of the RyR upon stimulation of the T-cell receptor. 100 mM 8-OCH 3 -cADPribose completely abolished OKT3 induced Ca 2+ signalling in T-lymphocytes as previously shown by Guse et al. (1999 ] i (t 600 ) is given for the indicated suramin concentrations in the injection pipette. The mean of the indicated number of experiments is given for each suramin concentration evaluated for the peak and t 600 time points. Error bars represent standard deviation. ; *results given in this report. ribose in a 10,0006g membrane fraction from Jurkat Tlymphocytes was suppressed in the presence of 20 mM of 8-OCH 3 -cADP-ribose . Co-injection of 10 mM suramin with 100 mM 8-OCH 3 -cADP-ribose had no eect on the mean peak [Ca 2+ ] i ( Figure 3B ). However, the t 600 values signi®cantly were reduced from 0.53+0.19 mM to 0.31+0.08 mM [Ca2+] i (P=0.023) ( Figure 3B ). These experiments imply that suramin exerts the RyR opening independent from the cADP-ribose binding site.
Discussion
The primary event in mammalian immune response to antigen exposure is the clonal activation of antigen-speci®c Tlymphocytes. The capability of T-lymphocytes to recognize and respond to antigenic stimuli is possible through the T-cell antigen receptor. Upon T-cell receptor activation multiple signalling cascades are activated (Berridge, 1997) . Ca 2+ mobilization is initiated by the generation of the second messengers IP 3 and cADP-ribose (Guse, 1999; Guse et al., 1999) and leads to the nuclear factor of activated T-cells (NF-AT)-dependent expression of interleukin-2 and chemokines (Alberola et al., 1997; Ward & Westwick, 1998) .
We have previously shown that the RyR is an essential player in T-lymphocyte activation. According to RT ± PCR the RyR of T-cells can be classi®ed as a type 3 RyR . In the present study we exploited the fact that the RyR type3 was the sole isoform present in Jurkat T-lymphocytes (Hakamata et al., 1994; Guse et al., 1999) . Therefore these cells represent an ideal tool to investigate the pharmacological regulation of this Ca 2+ channel and the role of this Ca 2+ store. The trypanocidal drug suramin is an agonist on the type 1 and type 2 RyR present in skeletal and cardiac muscle, respectively (Hohenegger et al., 1996) . For the RyR type 1 we recently showed that suramin antagonized calmodulin eects in a competitive manner (Klinger et al., 1999) . Furthermore the puri®ed type1 RyR immobilized on a calmodulinsepharose matrix was eluted by suramin. Taken together, these results argue for an agonistic eect of suramin mediated via a calmodulin binding site. Calmodulin binding sites are conserved in the type 3 RyR (Leeb & Brenig, 1998) . We have therefore applied suramin in increasing concentrations using the microinjection method in order to circumvent its poor membrane permeability. Our observations show that suramin induced a speci®c activation of the RyR based on the following arguments (for overview see Table 1 ): (i) extracellular application of suramin did not alter [Ca 2+ ] i ; (ii) co-injection of 10 mM suramin with 2 mM ruthenium red completely abolished the suramin induced Ca 2+ transient; (iii) the suramin induced Ca 2+ transients were strictly dose-dependent ( Figure  1B,C) . Small molecular mass proteins in the injection pipette are expected to be diluted in the cytosol at least 50 fold (Guse et al., 1997) .
Translation of this dilution factor results in an EC 50 for suramin of 70 ± 120 mM in the cell. This value is well within the ] i were summarized from microinjection experiments with 10 mM suramin (n=15) or co-injection of 10 mM suramin and 100 mM 8-OCH 3 -cADP-ribose (n=6). The bars represent the mean and the corresponding standard deviation.
range which was required for the RyR type 1 to promote [ 3 H]-ryanodine binding or single channel recording of the puri®ed receptor (Hohenegger et al., 1996) . The dose-response curve for suramin is very steep, resulting in a Hill coecient close to four. The ryanodine receptor exists as a homotetramer which shows cooperativity for most of the RyR ligands (Zucchi & Ronca-Testoni, 1997) . This assumption implies that this channel opens according to a threshold activation. Previous observations in single channel recordings of the puri®ed RyR type1 showed periods of continuous activation upon suramin addition for up to 2 min (Hohenegger et al., 1996) . A similar behaviour of the T-cell RyR may partially explain the fact that the suramin induced Ca 2+ signals in Jurkat T-lymphocytes are accompanied by sustained elevated [Ca 2+ ] i for more than 10 min ( Figure 1A) . Emmick et al. (1994) showed that suramin inhibited the Ca 2+ -ATPase of the rabbit skeletal muscle sarcoplasmic reticulum. Thus, sustained suramin-induced Ca 2+ signals may also be due to an inhibitory eect of suramin on the Ca 2+ -ATPase of the endoplasmic reticulum. However, we exclude this interpretation because the t 600 values were signi®cantly reduced in the presence of the antagonists for InsP 3 or cADPribose, which is unlikely due to reversal of the inhibition of the Ca 2+ -ATPase of the endoplasmic reticulum in Jurkat Tlymphocytes ( Figures 2B and 3B) .
However, how can the inhibition of the sustained phase of suramin-stimulated Ca 2+ signalling by Ins(1,4,6)PS 3 and 8-OCH 3 -cADP-ribose be explained? Presumably, there was an opening of the RyR directly after the microinjection of suramin, due to the high local suramin concentrations. The subsequent dilution of suramin within the cell then slowly terminated this primary eect. (Murayama & Ogawa, 1996; Hagar et al., 1998) . Both receptors were activated at submicromolar Ca 2+ concentrations. These properties may propagate the signal for a slow return of [Ca 2+ ] i to basal levels ( Figure 1A ). Since it is not possible to detect the basal InsP 3 and cADP-ribose levels on single cell levels in the absence or presence of microinjected suramin this interpretation is obviously speculative. However, by the addition of the antagonist (i.e. either Ins(1,4,6)PS 3 or 8-OCH 3 -cADP-ribose) the sustained [Ca 2+ ] i elevation was inhibited. Therefore, these antagonists lead to a considerably shortened Ca 2+ signal (Figures 2A and 3A) . Similar to suramin, caeine also activates the type1 and 2 RyR (Meissner, 1994; Zucchi & Ronca-Testoni, 1997 , Klinger et al., 1999 . However, the response of type3 RyR to caeine is still controversial. Giannini et al. (1992) and Hakamata et al. (1994) reported that caeine did not evoke an increase in [Ca 2+ ] i in mink lung epithelial cells and Jurkat T-lymphocytes, respectively, although a type 3 RyR was present in these cells. In contrast to these observations, Murayama & Ogawa, (1996) could clearly ®nd a Ca 2+ -dependent increase in [ 3 H]-ryanodine binding upon addition of caeine in rabbit brain membranes enriched in RyR type 3. These discrepancies in response to caeine and the fact that microinjection of caeine will lead to diusion to the extracellular solution makes this compound not comparable to suramin. In summary, evidence is provided for an agonistic eect of suramin on T-cell RyR opening and the possibility of immunopharmacological modulation of the T-cell activity via the cADP-ribose Ca 2+ -signalling pathway.
